Life Science Compliance Update

July

2018

Copay Assistance Lands Pfizer Another Corporate Integrity Agreement

Written by , Posted in Uncategorized

Kaitlin Fallon Wildoner, Esq.

Pfizer is the second company (of perhaps many) to find itself in a new corporate integrity agreement (CIA) over patient assistance programs and independent charities. The CIA entered between Pfizer and HHS-OIG, and the DOJ include some newer language and requirements centering around PAPs and give good insight into what other companies should be looking to do concerning their PAP arrangements.


   or   

  • Return to July 2018 LSC Update Table of Contents
  • Copy abstract URL
  • Order Reprints

  • January

    2018

    Like the Little Drummer Boy, the Beat Goes on as OIG Enforcement Shows Few Signs of Letting Up

    Written by , Posted in Uncategorized

    Kristen Schwendinger, Senior Managing Consultant, Berkley Research Group

    As life science compliance professionals know, it is important to monitor what the HHS OIG focuses on. This article reviews the OIG’s focus in 2017 and looks ahead to what may be in store for 2018.


       or   


    Menu Title